Amyloid pathology
Showing 1 - 25 of 3,578
Program to Identify Participants at High Risk for Amyloid
Not yet recruiting
- Alzheimer's Disease
- No Intervention
-
Lady Lake, Florida
- +1 more
Sep 12, 2023
OCTA Factors in or Without Amyloid Pathology: A Prospective
Completed
- Alzheimer Disease
- +4 more
-
Busan, Korea, Republic ofPusan National University Hospital
Jul 24, 2022
Alzheimer Trial in Bobigny (Fluorodeoxyglucose-PET, florbetapir F 18-PET)
Completed
- Alzheimer Disease
- Fluorodeoxyglucose-PET
- florbetapir F 18-PET
-
Bobigny, FranceHospital Avicenne-Neurology
Jan 12, 2021
Transthyretin Amyloid Cardiopathy, Mitochondrial Pathology Trial in Aarhus N (Trimetazidine, Placebo)
Recruiting
- Transthyretin Amyloid Cardiopathy
- Mitochondrial Pathology
- Trimetazidine
- Placebo
-
Aarhus N, Danmark, DenmarkAarhus University Hospital, Department of Cardiology
Jan 26, 2023
Alzheimer, Amyloid Plaque, Amyloidosis Trial (40 Hz multi-sensory (auditory + visual) stimulation and cognitive training,
Not yet recruiting
- Alzheimer Disease
- +2 more
- 40 Hz multi-sensory (auditory + visual) stimulation and cognitive training
- Cognitive training
- (no location specified)
May 28, 2021
Alzheimer Trial in Baltimore ([18F]P16-129)
Completed
- Alzheimer Disease
-
Baltimore, MarylandJohns Hopkins Medical Institutions
Jul 16, 2021
Frail Elderly Trial in Toulouse (MRI and PET scan)
Active, not recruiting
- Frail Elderly
- MRI and PET scan
-
Toulouse, FranceToulouse University Hospital (CHU de Toulouse)
Oct 13, 2022
Aortic Stenosis and Cardiac Amyloidosis
Recruiting
- Cardiac Amyloidosis
- Aortic Stenosis
- Amyloid-specific treatment
- No amyloid-specific treatment
-
Vienna, Austria
- +1 more
Nov 8, 2023
Alzheimer Trial in United States (Anti-amyloid Monoclonal Antibodies (mAbs), Standard of Care)
Not yet recruiting
- Alzheimer Disease
- Anti-amyloid Monoclonal Antibodies (mAbs)
- Standard of Care
-
Albany, Georgia
- +7 more
Aug 13, 2023
Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline Trial in Dallas (Angiotensin II Receptor Blockers
Recruiting
- Cognitively Normal Older Adults
- +3 more
- Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine)
- PCP
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Dec 1, 2022
Cholinergic Integrity in Down Syndrome in Association With
Recruiting
- Down Syndrome
- +2 more
- [18F]-FEOBV Radiotracer
-
Nashville, TennesseeVanderbilt University Medical Center Clinical Research Center
Jan 31, 2023
Lumbar Spine Stenosis Specimens for Identification of
Not yet recruiting
- Lumbar Spinal Stenosis
- +5 more
- Tc99-PYP or Tc99-HDMP Scan
-
Beverly Hills, California
- +5 more
Sep 12, 2023
Bioavailability, Gut Microbiome, Safety Trial in Lubbock (Low curcumin group, High curcumin group)
Not yet recruiting
- Bioavailability
- +2 more
- Low curcumin group
- High curcumin group
-
Lubbock, TexasTexas Tech University Health Sciences Center
Mar 15, 2023
Mild Cognitive Impairment, Healthy, Alzheimer Trial in Schlieren (18F-AV-1451 (Tau-PET tracer))
Active, not recruiting
- Mild Cognitive Impairment
- +3 more
- 18F-AV-1451 (Tau-PET tracer)
-
Schlieren, Zurich, SwitzerlandInstitute for Regenerative Medicine (IREM)
Dec 21, 2021
Alzheimer, Cognitive Decline Trial in Dallas ([18F]AV-1451, Positron Emission Tomography)
Completed
- Alzheimer Disease
- Cognitive Decline
- [18F]AV-1451
- Positron Emission Tomography
-
Dallas, TexasUT Southwestern Medical Center
Jul 28, 2022
Alzheimer Trial in Toronto (Deep Brain Stimulation)
Active, not recruiting
- Alzheimer Disease
- Deep Brain Stimulation
-
Toronto, Ontario, CanadaToronto Western Hospital, University Health Network
May 16, 2022
Alzheimer Trial in Boston (Transcranial Alternating Current Stimulation (tACS))
Completed
- Alzheimer Disease
- Transcranial Alternating Current Stimulation (tACS)
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Aug 18, 2022
Ovarian Cancer Trial in Birmingham ([11C]PiB and 18F-labeled DPA-714 PET scan)
Not yet recruiting
- Ovarian Cancer
- [11C]PiB and 18F-labeled DPA-714 PET scan
-
Birmingham, AlabamaThe University of Alabama at Birmingham
Jun 9, 2022
Alzheimer, Family Members Trial in Boston (GENUS)
Recruiting
- Alzheimer Disease
- Family Members
- GENUS
-
Boston, MassachusettsMassachusetts General Hospital
Mar 17, 2023
Database to Investigate Blood-Based and Digital Biomarkers in
Recruiting
- Alzheimer Disease
- +5 more
- Biomarker Data Collection
-
Aventura, Florida
- +15 more
Sep 21, 2022
Cardiac Amyloidosis Screening at Trigger Finger Release
Completed
- Amyloidosis
- +3 more
- Biopsy
-
Cleveland, OhioCleveland Clinic
Dec 21, 2021
Alzheimer Trial in Lille, Paris, Rouen ([11C]-UCB-J, [18F]-DPA-714, [18F]-RO-948)
Not yet recruiting
- Alzheimer Disease
- [11C]-UCB-J
- +3 more
-
Lille, France
- +2 more
Jun 12, 2023
The Swedish BioFINDER - Primary Care Study
Recruiting
- Mild Dementia
- +6 more
- Plasma APS 2 score
- +6 more
-
Malmö, SwedenPrimary care centers in Region Skåne
Nov 8, 2023
Screening for Systemic Amyloidosis Via the Ligamentum Flavum
Completed
- Amyloid
- +4 more
- Biopsy
-
Cleveland, OhioCleveland Clinic
Dec 21, 2021